AR043831A1 - Derivados de pirrodilina y procedimiento para prepararlos - Google Patents

Derivados de pirrodilina y procedimiento para prepararlos

Info

Publication number
AR043831A1
AR043831A1 ARP040101113A ARP040101113A AR043831A1 AR 043831 A1 AR043831 A1 AR 043831A1 AR P040101113 A ARP040101113 A AR P040101113A AR P040101113 A ARP040101113 A AR P040101113A AR 043831 A1 AR043831 A1 AR 043831A1
Authority
AR
Argentina
Prior art keywords
oxo
formula
compound
imino
hal
Prior art date
Application number
ARP040101113A
Other languages
English (en)
Spanish (es)
Inventor
Tsaklakidis Christos Dr
Cezanne Bertram Dr
Gleitz Johannes Dr
Mederski Werner Dr
Dipl Chem Dorsch Dieter Dr
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10315377A external-priority patent/DE10315377A1/de
Priority claimed from DE10327428A external-priority patent/DE10327428A1/de
Priority claimed from DE2003129295 external-priority patent/DE10329295A1/de
Priority claimed from DE2003134174 external-priority patent/DE10334174A1/de
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR043831A1 publication Critical patent/AR043831A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ARP040101113A 2003-04-03 2004-04-02 Derivados de pirrodilina y procedimiento para prepararlos AR043831A1 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10315377A DE10315377A1 (de) 2003-04-03 2003-04-03 Carbonylverbindungen
DE10327428A DE10327428A1 (de) 2003-06-18 2003-06-18 Ethinylprolinderivate
DE2003129295 DE10329295A1 (de) 2003-06-30 2003-06-30 Carbonylverbindungen
DE10329457A DE10329457A1 (de) 2003-04-03 2003-07-01 Ethinylprolinderivate
DE2003134174 DE10334174A1 (de) 2003-07-26 2003-07-26 Pyrrolidinderivate und Verfahren zur Herstellung

Publications (1)

Publication Number Publication Date
AR043831A1 true AR043831A1 (es) 2005-08-17

Family

ID=33136213

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101113A AR043831A1 (es) 2003-04-03 2004-04-02 Derivados de pirrodilina y procedimiento para prepararlos

Country Status (16)

Country Link
US (1) US7504500B2 (https=)
EP (1) EP1608646B1 (https=)
JP (1) JP4634369B2 (https=)
KR (1) KR20050118709A (https=)
AR (1) AR043831A1 (https=)
AT (1) ATE366732T1 (https=)
AU (1) AU2004226280B2 (https=)
BR (1) BRPI0408888A (https=)
CA (1) CA2520893C (https=)
DE (2) DE10329457A1 (https=)
ES (1) ES2287708T3 (https=)
MX (1) MXPA05010433A (https=)
PE (1) PE20050395A1 (https=)
PL (1) PL377138A1 (https=)
TW (1) TW200500339A (https=)
WO (1) WO2004087695A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050119266A1 (en) * 2003-10-01 2005-06-02 Yan Shi Pyrrolidine and piperidine derivatives as factor Xa inhibitors
DE102004004731A1 (de) * 2004-01-30 2005-08-18 Merck Patent Gmbh Harnstoffderivate
DE102004045796A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
DE102004047254A1 (de) * 2004-09-29 2006-04-13 Merck Patent Gmbh Carbonylverbindungen
DE102004050283A1 (de) * 2004-10-15 2006-04-27 Lanxess Deutschland Gmbh 4-Aminophenyl-morpholinon-Derivate und deren Herstellung
US7301817B2 (en) * 2005-10-27 2007-11-27 Sandisk Corporation Method for programming of multi-state non-volatile memory using smart verify
EP1951717A1 (en) * 2005-11-16 2008-08-06 F.Hoffmann-La Roche Ag Novel pyrrolidine derivatives as inhibitors of coagulation factor xa
EP1818330A1 (de) 2006-02-14 2007-08-15 Boehringer Ingelheim Pharma GmbH & Co.KG Substituierte Prolinamide, deren Herstellung und deren Verwendung als Arzneimittel
MY146623A (en) 2006-05-16 2012-09-14 Boehringer Ingelheim Int Substituted prolinamides, manufacturing, and the use thereof as medicaments
US8673920B2 (en) 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2012058116A1 (en) 2010-10-27 2012-05-03 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2632464B1 (en) 2010-10-29 2015-04-29 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AU2012299227A1 (en) 2011-08-19 2014-02-20 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013039802A1 (en) 2011-09-16 2013-03-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2771004B1 (en) 2011-10-25 2016-05-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US8999990B2 (en) 2011-10-25 2015-04-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013066714A1 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773206B1 (en) 2011-10-31 2018-02-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773351B1 (en) 2011-10-31 2017-08-23 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2790511B1 (en) 2011-12-16 2016-09-14 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
EP2925322B1 (en) 2012-11-29 2018-10-24 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9573961B2 (en) 2012-12-19 2017-02-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014126944A2 (en) 2013-02-18 2014-08-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2968288B1 (en) 2013-03-15 2018-07-04 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP3027625B1 (en) 2013-07-31 2018-05-30 Merck Sharp & Dohme Corp. Spiro-fused derivatives of piperidine useful for the treatment of inter alia hypertension and acute or chronic heart failure
WO2015065866A1 (en) 2013-10-31 2015-05-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822111B2 (ja) * 1977-10-29 1983-05-06 協和醗酵工業株式会社 柑橘類果実の改質剤
JPS63232846A (ja) * 1987-03-20 1988-09-28 Haruo Ogura 新規な固定相担体
WO1998022432A1 (en) * 1996-11-18 1998-05-28 Yamanouchi Pharmaceutical Co., Ltd. Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
US7030141B2 (en) * 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade

Also Published As

Publication number Publication date
CA2520893C (en) 2012-07-10
ES2287708T3 (es) 2007-12-16
TW200500339A (en) 2005-01-01
AU2004226280A1 (en) 2004-10-14
EP1608646A1 (de) 2005-12-28
US20060211692A1 (en) 2006-09-21
KR20050118709A (ko) 2005-12-19
EP1608646B1 (de) 2007-07-11
PL377138A1 (pl) 2006-01-23
BRPI0408888A (pt) 2006-04-11
MXPA05010433A (es) 2005-11-04
DE502004004294D1 (de) 2007-08-23
US7504500B2 (en) 2009-03-17
CA2520893A1 (en) 2004-10-14
ATE366732T1 (de) 2007-08-15
JP2006522037A (ja) 2006-09-28
DE10329457A1 (de) 2005-01-20
AU2004226280B2 (en) 2010-06-17
WO2004087695A1 (de) 2004-10-14
PE20050395A1 (es) 2005-06-04
JP4634369B2 (ja) 2011-02-16

Similar Documents

Publication Publication Date Title
AR043831A1 (es) Derivados de pirrodilina y procedimiento para prepararlos
ECSP034865A (es) Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas
CY1108445T1 (el) Νεα μεθοδος συνθεσης και νεα κρυσταλλικη μορφη της αγομελατινης καθως και φαρμακευτικες συνθεσεις που την περιεχουν
TR200400376T4 (tr) Yeni, ilaç olarak kullanılabilen antikolinerjikler ve bunların imalatı için yöntem
EA200970493A1 (ru) Макроциклические ингибиторы вируса гепатита с
AR063906A1 (es) Compuestos quimicos derivados del indazol, una composicion farmaceutica y procesos de prpeparacion de los compuestos
EA200501333A1 (ru) 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
AR048069A1 (es) Derivados de pirazolo con heteroarilo fusionado
EA200900817A1 (ru) Способ получения фторметилзамещённых гетероциклических соединений
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
ATE394413T1 (de) Peptidylketone als inhibitoren der dpiv
NO20042534L (no) Forbedringer vedrorende optiske lysgjoringsmidler
PE20091575A1 (es) Derivados bifenilo como inhibidores del virus de la hepatitis c
EA200601896A1 (ru) Производные пролина и их применение в качестве ингибиторов дипептидилпептидазы iv
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
MXPA05006907A (es) Compuestos diazoicos cationicos, composiciones que los contienen como colorante directo, procedimiento de coloracion de fibras queratinicas y dispositivo.
EA200800701A1 (ru) 4-замещенные пирролидин-2-оны и их применение
PE20100144A1 (es) Compuestos quimicos 293
ATE478054T1 (de) Benzimidazolderivate
EA200970124A1 (ru) Производные 2-арилиндола в качестве ингибиторов npges-1
CO5690551A2 (es) Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo
AR074593A1 (es) Benzotiazol amidas para la deteccion del peptido beta amiloide
MX2009005423A (es) Nuevo procedimiento para la preparacion de 4,4'-(1-metil-1,2-etand il)-bis-(2,6-piperazindiona).
AR054341A1 (es) Combinaciones sinergicas de compuestos activos fungicidas
RU2009120043A (ru) Соединение с амидной группой или его соль и ингибитор образования биопленки, средство для удаления биопленки и бактерицид, в каждом из которых используется соединение с амидной группой или его соль

Legal Events

Date Code Title Description
FB Suspension of granting procedure